Skip to content Skip to footer
Close
team-cordero

M.D.

Dr. Carlos Cordero-Garcia

Dr Cordero is Head of Physical Medicine & Rehabilitation Department at Juan Ramón Jiménez University Hospital. Huelva, Spain.

Spain

Biography

  • Head of Physical Medicine & Rehabilitation Department at Juan Ramón Jiménez University Hospital. Huelva, Spain.
  • Associate Professor. Faculty of Medicine. University of Huelva.
  • Director of Master in Neurorehabilitation. CEU University. Madrid, Spain.
  • International Site Director & Senior Teaching Assistant. PPCR Course. Department of Executive and Continuing Professional Education. Harvard TH Chan School of Public Health.
  • Member of the Group of Experts for MSK Conditions. World Health Organization.

    He teaches many national and international courses about botulinum toxin, ultrasound and ultrasound guided interventional procedures. His main areas of clinical and research interest include spasticity management, stroke rehabilitation, non invasive brain stimulation, and interventional pain management.

Other team members

team-balbert

Dr. Alexander Balbert

team-baricich

Prof. Alessio Baricich

team-bensmail

Prof. Djamel Bensmail

team-Bianchi

Dr.ssa. Francesca Bianchi

team-biering-sorenson

Dr. Bo Biering-Sørensen

team-carda

Dr. Stefano Carda

team-deltombe2

Prof. Thierry Deltombe

team-draulans

Dr. Nathalie Draulans

team-escaldi

Dr. Steven V. Escaldi

team-Francisco

Dr. Gerard E. Francisco

team-Gross

Prof. Raphaël Johannes Gross

team-JACINTO-teste

Dr. Luis Jorge Jacinto

team-molteni

Dr. Franco Molteni

team-odell

Prof. Michael O’Dell

team-Picelli

Prof. Alessandro Picelli

team-reebye

Prof. Rajiv Reebye

team-Santamato-2

Prof. Andrea Santamato

team-Schillebeeckx

Dr. Fabienne Schillebeeckx

team-verduzco

Prof. Monica Verduzco-Gutierrez

team-walker

Dr. Heather Walker

team-wissel

Prof. Jörg Wissel

team-zimmerman

Dr. Maximo Zimerman

Brenda McCleary, an independent consultant, provides general management and scientific support for Toxnet projects.

© 2025 ToxNet. All Rights Reserved.

Supported by Merz Therapeutics GmbH

Liability for links
Our site contains links to external websites, over which we have no control. Therefore we cannot accept any responsibility for this external content. The respective provider or operator is always responsible for the contents of any linked site. At the time of linking the linked sites where checked for possible legal violations. At the time of linking illegal contents were not indicated. A permanent control of the linked pages is unreasonable without concrete evidence of violation. Upon notification of violations, we will remove such links immediately.

Award scoring criteria

The following criteria will be judged out of a score of 5; (1 is suboptimal; 2 is adequate; 3 is good; 4 is very good; 5 is excellent)

GENERAL

  • Days per week working in spasticity management
  • Average number of spasticity patients managed per month
  • Environment and clinical team (type of institution, location, size/structure of clinical team, particular patient needs)
  • Role of responsibility in managing patients with spasticity
  • Scientific appointments in spasticity
  • Honours for work undertaken in spasticity

SCHOLARLY

  • Number of research projects investigating relevant aspects of spasticity management
  • Impact of research projects investigating relevant aspects of spasticity management
  • Number of peer-reviewed publications on topic
    Number of presentations of research at international meetings
  • Number of presentations at national conferences
  • Teaching/mentorship of younger injectors
  • h-index

CLINICAL

  • Evidence of development or growth of a spasticity program at the applicant’s practice or institution
  • Breadth of services provided, including medications, toxins, physical interventions, and Intrathecal Baclofen Therapy (ITB)
  • Role of responsibility in managing patients with spasticity

ENDORSEMENT

  • Endorsed by senior peer

In the event of a tie, based on the above scoring criteria, the Toxnet Co-Chairs will make the final decision.